Northern Trust Corp Acadia Pharmaceuticals Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Northern Trust Corp holds 1,126,130 shares of ACAD stock, worth $19.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,126,130

Previous 1,144,758 1.63%

Holding current value

$19.2 Million

Previous $18.6 Million 6.83%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.14 - $19.14 $282,027 - $356,539	-18,628 Reduced 1.63%	1,126,130 $17.3 Million
Q2 2024 Aug 14, 2024	SELL	$14.62 - $18.42 $688,134 - $866,992	-47,068 Reduced 3.95%	1,144,758 $18.6 Million
Q1 2024 May 14, 2024	SELL	$17.79 - $30.86 $396,841 - $688,394	-22,307 Reduced 1.84%	1,191,826 $22 Million
Q4 2023 Feb 13, 2024	SELL	$20.78 - $31.77 $135,984 - $207,902	-6,544 Reduced 0.54%	1,214,133 $38 Million
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $1.2 Million - $1.93 Million	57,555 Added 4.95%	1,220,677 $25.4 Million
Q2 2023 Aug 11, 2023	SELL	$17.8 - $25.65 $64,115 - $92,391	-3,602 Reduced 0.31%	1,163,122 $27.9 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $643,660 - $825,084	39,440 Added 3.5%	1,166,724 $22 Million
Q4 2022 Feb 13, 2023	BUY	$14.2 - $18.63 $146,899 - $192,727	10,345 Added 0.93%	1,127,284 $17.9 Million
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $195,395 - $253,002	-13,848 Reduced 1.22%	1,116,939 $18.3 Million
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $517,524 - $1.08 Million	-39,779 Reduced 3.4%	1,130,787 $15.9 Million
Q1 2022 May 13, 2022	SELL	$20.94 - $27.5 $1.13 Million - $1.49 Million	-54,096 Reduced 4.42%	1,170,566 $28.4 Million
Q4 2021 Feb 08, 2022	SELL	$16.79 - $27.09 $1.25 Million - $2.02 Million	-74,657 Reduced 5.75%	1,224,662 $28.6 Million
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $636,423 - $998,998	-40,331 Reduced 3.01%	1,299,319 $21.6 Million
Q2 2021 Aug 13, 2021	BUY	$19.4 - $27.42 $14.2 Million - $20.1 Million	733,652 Added 121.07%	1,339,650 $32.7 Million
Q1 2021 May 12, 2021	BUY	$25.02 - $54.99 $215,797 - $474,288	8,625 Added 1.44%	605,998 $15.6 Million
Q4 2020 Feb 11, 2021	BUY	$41.04 - $56.79 $389,469 - $538,937	9,490 Added 1.61%	597,373 $31.9 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $616,117 - $964,269	-16,917 Reduced 2.8%	587,883 $24.3 Million
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $35 Million - $47.1 Million	-892,709 Reduced 59.61%	604,800 $29.3 Million
Q1 2020 May 14, 2020	BUY	$31.65 - $46.87 $695,951 - $1.03 Million	21,989 Added 1.49%	1,497,509 $63.3 Million
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $1.99 Million - $2.82 Million	54,925 Added 3.87%	1,475,520 $63.1 Million
Q3 2019 Nov 13, 2019	SELL	$22.22 - $44.01 $1.07 Million - $2.12 Million	-48,189 Reduced 3.28%	1,420,595 $51.1 Million
Q2 2019 Aug 13, 2019	SELL	$23.32 - $28.12 $416,541 - $502,279	-17,862 Reduced 1.2%	1,468,784 $39.3 Million
Q1 2019 May 13, 2019	BUY	$16.17 - $27.38 $2.32 Million - $3.92 Million	143,297 Added 10.67%	1,486,646 $39.9 Million
Q4 2018 Feb 12, 2019	BUY	$14.32 - $22.92 $808,349 - $1.29 Million	56,449 Added 4.39%	1,343,349 $21.7 Million
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $330,505 - $553,210	25,365 Added 2.01%	1,286,900 $26.7 Million
Q2 2018 Sep 18, 2018	SELL	$15.07 - $22.34 $122,217 - $181,177	-8,110 Reduced 0.64%	1,261,535 $19.3 Million
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $11.8 Million - $17.4 Million	779,741 Added 159.16%	1,269,645 $19.4 Million
Q1 2018 May 09, 2018	BUY	$22.47 - $32.33 $397,269 - $571,594	17,680 Added 3.74%	489,904 $11 Million
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $18,546 - $27,045	691 Added 0.15%	472,224 $14.2 Million
Q3 2017 Nov 13, 2017	BUY	$29.49 - $38.37 $13.9 Million - $18.1 Million	471,533	471,533 $17.8 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Acadia Pharmaceuticals Inc Transaction History